BRAF c.101_102delinsAC ;(p.A34D)

Variant ID: 7-140624402-CG-GT

NM_004333.4(BRAF):c.101_102delinsAC;(p.A34D)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways.

Frontiers In Neuroscience
Attilio, Peter J PJ; Snapper, Dustin M DM; Rusnak, Milan M; Isaac, Akira A; Soltis, Anthony R AR; Wilkerson, Matthew D MD; Dalgard, Clifton L CL; Symes, Aviva J AJ
Publication Date: 2021

Variant appearance in text: BRAF: A34D
PubMed Link: 33828448
Variant Present in the following documents:
  • Main text
View BVdb publication page



A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).

International Journal Of Clinical Oncology
Shinozaki, Katsunori K; Yamada, Takeshi T; Nasu, Junichiro J; Matsumoto, Toshihiko T; Yuasa, Yasuhiro Y; Shiraishi, Takeshi T; Nagano, Hiroaki H; Moriyama, Ichiro I; Fujiwara, Toshiyoshi T; Miguchi, Masashi M; Yoshida, Ryosuke R; Nozaka, Kimiyasu K; Tanioka, Hiroaki H; Nagasaka, Takeshi T; Kurisu, Yasuro Y; Kobayashi, Michiya M; Tsuchihashi, Kenji K; Inukai, Michio M; Kikuchi, Takashi T; Nishina, Tomohiro T
Publication Date: 2021-02

Variant appearance in text: BRAF: A34D
PubMed Link: 33097971
Variant Present in the following documents:
  • Main text
View BVdb publication page